Managing financial and nonfinancial conflicts of interest in healthcare delivery

American Journal of Therapeutics

Volumn 17, Issue 4, 2010, Pages 440-443

  Kesselheim, Aaron S ^a   Maisel, William H ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

conflict of interest; FDA; medical device; regulatory affairs

Indexed keywords

CONFLICT OF INTEREST; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; HEALTH CARE DELIVERY; HEALTH CARE POLICY; NOTE; PATIENT RIGHT; PATIENT SAFETY; PRIORITY JOURNAL; DEVICES; ECONOMICS; ETHICS; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL ETHICS; ORGANIZATION AND MANAGEMENT; PHYSICIAN; PHYSICIAN ATTITUDE; POLICY;

CONFLICT OF INTEREST; DELIVERY OF HEALTH CARE; DISCLOSURE; EQUIPMENT AND SUPPLIES; ETHICS, MEDICAL; HUMANS; ORGANIZATIONAL POLICY; PHYSICIAN'S ROLE; PHYSICIANS;

EID: 77955013278     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3181d01cae     Document Type: Note

References (17)

1. Thompson DF. Understanding financial conflicts of interest. N Engl J Med. 1993;329:573-576.
2. Moore v. Regents of the Univ. of Cal., 793 P.2d 479 (Cal. 1990).
3. Chimonas S, Brennan TA, Rothman DJ. Physicians and drug representatives: exploring the dynamics of the relationship. J Gen Intern Med. 2007;22:184-190.
4. Manchanda P, Honka E. The effects and role of direct-tophysician marketing in the pharmaceutical industry: an integrative review. Yale J Health Policy Law Ethics. 2005;5: 785-812.
5. Shuster E. Fifty years later: the significance of the Nuremberg Code. N Engl J Med. 1997;337:1436-1440.
6. Campbell EG, Weissman JS, Ehringhaus S, et al. Institutional academic industry relationships. JAMA. 2007; 298:1779-1786.
7. Buchkowsky SS, Jewesson PJ. Industry sponsorship and authorship of clinical trials over 20 years. Ann Pharmacother. 2004;38:579-585.
8. Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA. 2006;295: 429-433.
9. Steinbrook R. Online disclosure of physician-industry relationships. N Engl J Med. 2009;360:325-327.
10. Vermont Stat Ann.§ 4631(b) (2009).
11. Ehringhaus SH, Weissman JS, Sears JL, et al. Responses of medical schools to institutional conflicts of interest. JAMA. 2008;299:665-671.
12. Weinfurt KP, Dinan MA, Allsbrook JS, et al. Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants. Acad Med. 2006;81:113-118.
13. Levinsky NG. Nonfinancial conflicts of interest in research. N Engl J Med. 2002;347:759-762.
14. Maj M. Non-financial conflicts of interest in psychiatric research and practice. Br J Psychiatry. 2008;193:91-92.
15. Horrobin DF. Non-financial conflicts of interest are more serious than financial conflicts. BMJ. 1999;318:466.
16. Sage WM. Some principles require principals: why banning-conflicts of interest won't solve incentive problems in biomedical research. Texas Law Rev. 2007; 85:1413-1463.
17. International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. Available at: http://www.icmje.org/ethical- 4conflicts.html. Accessed February 10, 2010.